Підписатись
BEAULIEU SERGE
BEAULIEU SERGE
Підтверджена електронна адреса в mcgill.ca
Назва
Посилання
Посилання
Рік
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar …
LN Yatham, SH Kennedy, SV Parikh, A Schaffer, DJ Bond, BN Frey, ...
Bipolar disorders 20 (2), 97-170, 2018
14152018
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of …
LN Yatham, SH Kennedy, SV Parikh, A Schaffer, S Beaulieu, M Alda, ...
Bipolar disorders 15 (1), 1-44, 2013
10592013
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of …
LN Yatham, SH Kennedy, A Schaffer, SV Parikh, S Beaulieu, ...
Bipolar disorders 11 (3), 225-255, 2009
7762009
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies
LN Yatham, SH Kennedy, C O'Donovan, S Parikh, G MacQueen, ...
Bipolar disorders 7, 5-69, 2005
5092005
Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives
T Baptista, N Kin, S Beaulieu, EA De Baptista
Pharmacopsychiatry 35 (06), 205-219, 2002
3902002
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007
LN Yatham, SH Kennedy, C O'Donovan, SV Parikh, G MacQueen, ...
Bipolar disorders 8 (6), 721-739, 2006
3262006
The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments
F Ng, OK Mammen, I Wilting, GS Sachs, IN Ferrier, F Cassidy, S Beaulieu, ...
Bipolar disorders 11 (6), 559-595, 2009
2162009
Control of ACTH secretion by the central nucleus of the amygdala: implication of the serotoninergic system and its relevance to the glucocorticoid delayed negative feedback …
S Beaulieu, T Di Paolo, N Barden
Neuroendocrinology 44 (2), 247-254, 1986
2061986
Differential effects of adrenergic and corticosteroid hormonal systems on human short-and long-term declarative memory for emotionally arousing material.
FS Maheu, R Joober, S Beaulieu, SJ Lupien
Behavioral neuroscience 118 (2), 420, 2004
2052004
Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial
T Baptista, N Rangel, V Fernández, E Carrizo, Y El Fakih, E Uzcátegui, ...
Schizophrenia research 93 (1-3), 99-108, 2007
1972007
Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial
T Baptista, J Martínez, A Lacruz, N Rangel, S Beaulieu, A Serrano, ...
The Canadian Journal of Psychiatry 51 (3), 192-196, 2006
1942006
Participation of the central amygdaloid nucleus in the response of adrenocorticotropin secretion to immobilization stress: opposing roles of the noradrenergic and dopaminergic …
S Beaulieu, T DiPaolo, J Côté, N Barden
Neuroendocrinology 45 (1), 37-46, 1987
1921987
A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study
SV Parikh, A Zaretsky, S Beaulieu, LN Yatham, LT Young, I Patelis-Siotis, ...
The Journal of clinical psychiatry 73 (6), 16669, 2012
1792012
Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures
MC Pepin, S Beaulieu, N Barden
Molecular Brain Research 6 (1), 77-83, 1989
1621989
Pharmacological management of atypical antipsychotic-induced weight gain
T Baptista, Y ElFakih, E Uzcátegui, I Sandia, E Tálamo, EA de Baptista, ...
CNS drugs 22, 477-495, 2008
1552008
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit …
DJ Bond, G Hadjipavlou, RW Lam, RS McIntyre, S Beaulieu, A Schaffer, ...
Ann Clin Psychiatry 24 (1), 23-37, 2012
1542012
Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics
T Baptista, J Zarate, R Joober, C Colasante, S Beaulieu, X Paez, ...
Current Drug Targets 5 (3), 279-299, 2004
1492004
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders
RS McIntyre, M Alsuwaidan, BI Goldstein, VH Taylor, A Schaffer, ...
Ann Clin Psychiatry 24 (1), 69-81, 2012
1432012
Rapid cycling bipolar disorder–diagnostic concepts
M Bauer, S Beaulieu, DL Dunner, B Lafer, R Kupka
Bipolar disorders 10 (1p2), 153-162, 2008
1282008
Comparative effects of the antipsychotics sulpiride or risperidone in rats: I: Bodyweight, food intake, body composition, hormones and glucose tolerance
T Baptista, EA de Baptista, NMKNY Kin, S Beaulieu, D Walker, R Joober, ...
Brain Research 957 (1), 144-151, 2002
1282002
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20